Video

Understanding the Basics of Ovarian Cancer

Author(s):

Kristie L. Kahl

On behalf of the National Ovarian Cancer Coalition, CURE spoke with Dr. Debra Richardson, from Stevenson Cancer Center, about the basics of ovarian cancer and its treatments, clinical trials and psychosocial effects.

Related Videos
Dr. Alex Francoeur interviewing against a gray CURE background
Related Content
"FDA" text.
November 1st 2024

Application Submitted to FDA for Avutometinib Plus Defactinib in Rare Ovarian Cancer

Darlene Dobkowski, MA
The FDA received the New Drug Application for avutometinib plus defactinib as a potential treatment option for previously treated low-grade serous ovarian cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a female reproductive system.
October 21st 2024

Avutometinib and Defactinib May Benefit Some with Ovarian Cancer

Alex Biese
Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.
Shannon Miller smiling at a podium while delivering the keynote address at the 2023 Extraordinary Healer event | Image credit: © ATA-GIRL PHOTOGRAPHY
May 4th 2023

Olympian Shares Her Cancer Experience: ‘Give Yourself Grace’

Brielle Benyon
Olympic gymnast, Shannon Miller, sat down with CURE® to discuss her experience with a rare type of ovarian cancer, and how her competitive mindset helped her through.
Image of Ann Wilson with sister Nancy Wilson - Jamie McCarthy via Getty Images
September 27th 2024

Ann Wilson of Heart Returns After Chemo, Ryan Reynolds Visits Young Patient and More

Alex Biese Ashley Chan
From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.
Illustration of ovaries.
September 26th 2024

Cediranib Added to Lynparza Didn’t Improve Progression, Survival in Ovarian Cancer

Ashley Chan
A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.